Luly Jay R.
- SEC CIK
- 0001571211
In the past year, 1 open-market sale filing worth $67.5K and no purchases.
Current role at each company
- ENTA Enanta Pharmaceuticals IncPresident and CEOas of Feb 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $67.5K
- 1 filing
- Net
- −$67.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Luly Jay R. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 (view filing) | Dec 5 | Same day | Luly Jay R.President and CEO | SSale | −4.74K | $14.23 | −$67.5K | −0.5%858.0K after | |
| Feb 12, 2025 (view filing) | Feb 12 | Same day | Luly Jay R.President and CEO | PPurchase | +45.0K | $5.69 | +$256.1K | +5.6%846.6K after | |
| Dec 10, 2024 (view filing) | Dec 6 | 4 days | Luly Jay R.President and CEO | SSale | −5.14K | $8.06 | −$41.4K | −0.6%801.6K after | 10b5-1 |
| Dec 6, 2023 (view filing) | Dec 5 | 1 day | Luly Jay R.President and CEO | SSale | −7.23K | $9.63 | −$69.6K | −0.9%806.8K after | |
| Mar 14, 2023 (view filing) | Mar 13 | 1 day | Luly Jay R.President and CEO | SSale | −27.9K | $45.16 | −$1.26M | −3.3%819.8K after | 3 lots |
| Dec 16, 2022 (view filing) | Dec 16 | Same day | Luly Jay R.President and CEO | SSale | −30.0K | $44.72 | −$1.34M | −3.7%773.8K after | 3 lots |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Luly Jay R.President and CEO | SSale | −4.52K | $59.06 | −$266.7K | −0.7%677.0K after |